Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice

BACKGROUND: Despite exciting new targeted therapeutics against non-Hodgkin's lymphoma (NHL), chemotherapy remains a cornerstone of therapy. While purine nucleoside analogs have significant activity in low grade NHL, the pyrimidine nucleoside analog gemcitabine has been less extensively studied,...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Mitchell R, Joshi, Indira, Jin, Fang, Obasaju, Coleman
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1208862/
https://www.ncbi.nlm.nih.gov/pubmed/16109167
http://dx.doi.org/10.1186/1471-2407-5-103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1208862/
https://www.ncbi.nlm.nih.gov/pubmed/16109167
http://dx.doi.org/10.1186/1471-2407-5-103

Ejemplares similares